Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Allegion plcALLE · Entity 3420 | Director | August 28, 2026 | August 31, 2026 |
| GRAIL, Inc.GRAL · Entity 4122 | Director | July 15, 2026 | July 16, 2026 |
| GROUP 1 AUTOMOTIVE INCGPI · Entity 1789 | Director | January 02, 2026 | January 06, 2026 |
| Merck & Co., Inc.MRK · Entity 2807 | EVP, Chief HR Officer | February 02, 2024 | February 02, 2024 |
| OSHKOSH CORPOSK · Entity 3573 | Director | November 19, 2018 | November 21, 2018 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Allegion plc
Report date August 28, 2026 · Filed August 31, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary SharesSEC Table I · non-derivative | Direct | 5,899 |
Reported balance
After 2026-08-28 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-08-28 · Purchase · Acquired 170 · Balance 5,899 F1: Includes shares acquired through a dividend reinvestment plan since the Reporting Person's last Form 4 filing. |
Filing footnotes · ownership attribution and instrument terms
F1: Includes shares acquired through a dividend reinvestment plan since the Reporting Person's last Form 4 filing.
GRAIL, Inc.
Report date July 15, 2026 · Filed July 16, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 42,830 |
Reported balance
After 2026-07-15 transaction · row 1
1 source rowRow 1 · 2026-07-15 · Grant · Acquired 268 · Balance 42,830 F1: Represents 268 deferred stock units granted to Mr. Mizell under our deferred stock program and 2024 Equity Incentive Plan in lieu of $19,945.21 of cash fees payable to Mr. Mizell for his service as a director, based on a price per share of $74.36, which was the closing price per share of the Company's common stock on July 15, 2026. The awards will vest immediately upon grant date. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents 268 deferred stock units granted to Mr. Mizell under our deferred stock program and 2024 Equity Incentive Plan in lieu of $19,945.21 of cash fees payable to Mr. Mizell for his service as a director, based on a price per share of $74.36, which was the closing price per share of the Company's common stock on July 15, 2026. The awards will vest immediately upon grant date.
GROUP 1 AUTOMOTIVE INC
Report date January 02, 2026 · Filed January 06, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 583 |
Reported balance
After 2026-01-02 transaction · row 1
1 source rowRow 1 · 2026-01-02 · Grant · Acquired 575 · Balance 583 |
Merck & Co., Inc.
Report date February 02, 2024 · Filed February 02, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 23,619.145 |
Ending reported balance
After 2024-02-02 transaction · row 3
3 source rows · reconciled sequenceRow 1 · 2024-02-02 · Exercise / conversion · Acquired 824 · Balance 42,143.145 Row 2 · 2024-02-02 · Exercise / conversion · Acquired 32,170 · Balance 74,313.145 Row 3 · 2024-02-02 · Sale · Disposed 50,694 · Balance 23,619.145 F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $126.4300 to $126.9000, inclusive. The reporting person undertakes to provide to Merck & Co., Inc., any security holder of Merck & Co., Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $70.71 · Expires 2028-10-29 | Direct | 0 |
Reported balance
After 2024-02-02 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2024-02-02 · Exercise / conversion · Disposed 824 · Balance 0 F2: The option vested and became exercisable in three equal installments on 10/30/2019, 10/30/2020 and 10/30/2021. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $73.73 · Expires 2031-05-03 | Direct | 22,088 |
Reported balance
After 2024-02-02 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2024-02-02 · Exercise / conversion · Disposed 32,170 · Balance 22,088 F3: The option vests and becomes exercisable in three equal installments on 5/4/2022, 5/4/2023 and 5/4/2024. |
Filing footnotes · ownership attribution and instrument terms
F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $126.4300 to $126.9000, inclusive. The reporting person undertakes to provide to Merck & Co., Inc., any security holder of Merck & Co., Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F2: The option vested and became exercisable in three equal installments on 10/30/2019, 10/30/2020 and 10/30/2021.
F3: The option vests and becomes exercisable in three equal installments on 5/4/2022, 5/4/2023 and 5/4/2024.
OSHKOSH CORP
Report date November 19, 2018 · Filed November 21, 2018
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 11,660.31 |
Reported balance
After 2018-11-19 transaction · row 1
1 source rowRow 1 · 2018-11-19 · Grant · Acquired 47.34 · Balance 11,660.31 F1: Represents stock units payable in Oshkosh Corporation common stock acquired in accordance with the dividend reinvestment feature of the Oshkosh Corporation Deferred Compensation Plan for Directors and Executive Officers. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents stock units payable in Oshkosh Corporation common stock acquired in accordance with the dividend reinvestment feature of the Oshkosh Corporation Deferred Compensation Plan for Directors and Executive Officers.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
MONSANTO CO /NEW/
Report date June 07, 2018 · Filed June 07, 2018
Section 16 reporting ended · disclosed 2018-06-07. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2018-06-07 transaction · row 1
Sequence does not reconcile; account continuity is unresolved.
1 source rowRow 1 · 2018-06-07 · Disposition to issuer · Disposed 62 · Balance 0 F1: Pursuant to the terms of and subject to certain exceptions set forth in the Agreement and Plan of Merger, dated as of September 14, 2016 (the "Merger Agreement"), by and among Bayer Aktiengesellschaft ("Bayer"), KWA Investment Co. ("Merger Sub") and Monsanto Company (the "Company"), each share of common stock of the Company and each time- or performance-vesting restricted stock unit of the Company outstanding immediately prior to the effective time of the merger (the "Effective Time") was automatically converted into the right to receive $128.00 in cash, without interest (the "Merger Consideration"). F2: (Continued from Footnote 1) The Merger Consideration that is payable in respect of restricted stock units of the Company that were granted (a) prior to September 14, 2016 is fully vested as of the Effective Time or (b) after September 14, 2016 will vest based upon the vesting schedule applicable to the corresponding restricted stock units (subject to accelerated vesting in full upon a termination of employment without cause, for good reason or due to death, disability or retirement). Any Merger Consideration that is not paid at the Effective Time will begin accruing interest as of the Effective Time at the short-term federal rate. |
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2018-06-07 transaction · row 3
Sequence does not reconcile; account continuity is unresolved.
1 source rowRow 3 · 2018-06-07 · Disposition to issuer · Disposed 48,581 · Balance 0 F4: Represents restricted stock units. F1: Pursuant to the terms of and subject to certain exceptions set forth in the Agreement and Plan of Merger, dated as of September 14, 2016 (the "Merger Agreement"), by and among Bayer Aktiengesellschaft ("Bayer"), KWA Investment Co. ("Merger Sub") and Monsanto Company (the "Company"), each share of common stock of the Company and each time- or performance-vesting restricted stock unit of the Company outstanding immediately prior to the effective time of the merger (the "Effective Time") was automatically converted into the right to receive $128.00 in cash, without interest (the "Merger Consideration"). F2: (Continued from Footnote 1) The Merger Consideration that is payable in respect of restricted stock units of the Company that were granted (a) prior to September 14, 2016 is fully vested as of the Effective Time or (b) after September 14, 2016 will vest based upon the vesting schedule applicable to the corresponding restricted stock units (subject to accelerated vesting in full upon a termination of employment without cause, for good reason or due to death, disability or retirement). Any Merger Consideration that is not paid at the Effective Time will begin accruing interest as of the Effective Time at the short-term federal rate. |
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2018-06-07 transaction · row 4
Sequence does not reconcile; account continuity is unresolved.
1 source rowRow 4 · 2018-06-07 · Disposition to issuer · Disposed 19,787 · Balance 0 F5: Represents performance-based restricted stock units. F1: Pursuant to the terms of and subject to certain exceptions set forth in the Agreement and Plan of Merger, dated as of September 14, 2016 (the "Merger Agreement"), by and among Bayer Aktiengesellschaft ("Bayer"), KWA Investment Co. ("Merger Sub") and Monsanto Company (the "Company"), each share of common stock of the Company and each time- or performance-vesting restricted stock unit of the Company outstanding immediately prior to the effective time of the merger (the "Effective Time") was automatically converted into the right to receive $128.00 in cash, without interest (the "Merger Consideration"). F2: (Continued from Footnote 1) The Merger Consideration that is payable in respect of restricted stock units of the Company that were granted (a) prior to September 14, 2016 is fully vested as of the Effective Time or (b) after September 14, 2016 will vest based upon the vesting schedule applicable to the corresponding restricted stock units (subject to accelerated vesting in full upon a termination of employment without cause, for good reason or due to death, disability or retirement). Any Merger Consideration that is not paid at the Effective Time will begin accruing interest as of the Effective Time at the short-term federal rate. |
| Common StockSEC Table I · non-derivative | IndirectBy 401(k) Plan | 0 |
Reported balance
After 2018-06-07 transaction · row 2
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 2 · 2018-06-07 · Disposition to issuer · Disposed 1,024 · Balance 0 F1: Pursuant to the terms of and subject to certain exceptions set forth in the Agreement and Plan of Merger, dated as of September 14, 2016 (the "Merger Agreement"), by and among Bayer Aktiengesellschaft ("Bayer"), KWA Investment Co. ("Merger Sub") and Monsanto Company (the "Company"), each share of common stock of the Company and each time- or performance-vesting restricted stock unit of the Company outstanding immediately prior to the effective time of the merger (the "Effective Time") was automatically converted into the right to receive $128.00 in cash, without interest (the "Merger Consideration"). F2: (Continued from Footnote 1) The Merger Consideration that is payable in respect of restricted stock units of the Company that were granted (a) prior to September 14, 2016 is fully vested as of the Effective Time or (b) after September 14, 2016 will vest based upon the vesting schedule applicable to the corresponding restricted stock units (subject to accelerated vesting in full upon a termination of employment without cause, for good reason or due to death, disability or retirement). Any Merger Consideration that is not paid at the Effective Time will begin accruing interest as of the Effective Time at the short-term federal rate. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $58.71 | Direct | 0 |
Reported balance
After 2018-06-07 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2018-06-07 · Disposition to issuer · Disposed 7 · Balance 0 F3: Pursuant to the terms of the Merger Agreement, each option to purchase shares of common stock of the Company outstanding immediately prior to the Effective Time, whether vested or unvested, was automatically converted into the right to receive the Merger Consideration less the applicable exercise price of such option, without interest. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $74.79 | Direct | 0 |
Reported balance
After 2018-06-07 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2018-06-07 · Disposition to issuer · Disposed 70 · Balance 0 F3: Pursuant to the terms of the Merger Agreement, each option to purchase shares of common stock of the Company outstanding immediately prior to the Effective Time, whether vested or unvested, was automatically converted into the right to receive the Merger Consideration less the applicable exercise price of such option, without interest. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $90.48 | Direct | 0 |
Reported balance
After 2018-06-07 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2018-06-07 · Disposition to issuer · Disposed 91 · Balance 0 F3: Pursuant to the terms of the Merger Agreement, each option to purchase shares of common stock of the Company outstanding immediately prior to the Effective Time, whether vested or unvested, was automatically converted into the right to receive the Merger Consideration less the applicable exercise price of such option, without interest. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $106.05 | Direct | 0 |
Reported balance
After 2018-06-07 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2018-06-07 · Disposition to issuer · Disposed 80 · Balance 0 F3: Pursuant to the terms of the Merger Agreement, each option to purchase shares of common stock of the Company outstanding immediately prior to the Effective Time, whether vested or unvested, was automatically converted into the right to receive the Merger Consideration less the applicable exercise price of such option, without interest. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $112.82 | Direct | 0 |
Reported balance
After 2018-06-07 transaction · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · 2018-06-07 · Disposition to issuer · Disposed 5,764 · Balance 0 F3: Pursuant to the terms of the Merger Agreement, each option to purchase shares of common stock of the Company outstanding immediately prior to the Effective Time, whether vested or unvested, was automatically converted into the right to receive the Merger Consideration less the applicable exercise price of such option, without interest. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $91.34 | Direct | 0 |
Reported balance
After 2018-06-07 transaction · row 10
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 10 · 2018-06-07 · Disposition to issuer · Disposed 7,234 · Balance 0 F3: Pursuant to the terms of the Merger Agreement, each option to purchase shares of common stock of the Company outstanding immediately prior to the Effective Time, whether vested or unvested, was automatically converted into the right to receive the Merger Consideration less the applicable exercise price of such option, without interest. |
| Deferred Payment Plan Restricted Stock UnitSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2018-06-07 transaction · row 11
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 11 · 2018-06-07 · Disposition to issuer · Disposed 1,926 · Balance 0 F1: Pursuant to the terms of and subject to certain exceptions set forth in the Agreement and Plan of Merger, dated as of September 14, 2016 (the "Merger Agreement"), by and among Bayer Aktiengesellschaft ("Bayer"), KWA Investment Co. ("Merger Sub") and Monsanto Company (the "Company"), each share of common stock of the Company and each time- or performance-vesting restricted stock unit of the Company outstanding immediately prior to the effective time of the merger (the "Effective Time") was automatically converted into the right to receive $128.00 in cash, without interest (the "Merger Consideration"). F2: (Continued from Footnote 1) The Merger Consideration that is payable in respect of restricted stock units of the Company that were granted (a) prior to September 14, 2016 is fully vested as of the Effective Time or (b) after September 14, 2016 will vest based upon the vesting schedule applicable to the corresponding restricted stock units (subject to accelerated vesting in full upon a termination of employment without cause, for good reason or due to death, disability or retirement). Any Merger Consideration that is not paid at the Effective Time will begin accruing interest as of the Effective Time at the short-term federal rate. |
| Phantom Share UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2018-06-07 transaction · row 12
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 12 · 2018-06-07 · Disposition to issuer · Disposed 16,473 · Balance 0 F1: Pursuant to the terms of and subject to certain exceptions set forth in the Agreement and Plan of Merger, dated as of September 14, 2016 (the "Merger Agreement"), by and among Bayer Aktiengesellschaft ("Bayer"), KWA Investment Co. ("Merger Sub") and Monsanto Company (the "Company"), each share of common stock of the Company and each time- or performance-vesting restricted stock unit of the Company outstanding immediately prior to the effective time of the merger (the "Effective Time") was automatically converted into the right to receive $128.00 in cash, without interest (the "Merger Consideration"). F2: (Continued from Footnote 1) The Merger Consideration that is payable in respect of restricted stock units of the Company that were granted (a) prior to September 14, 2016 is fully vested as of the Effective Time or (b) after September 14, 2016 will vest based upon the vesting schedule applicable to the corresponding restricted stock units (subject to accelerated vesting in full upon a termination of employment without cause, for good reason or due to death, disability or retirement). Any Merger Consideration that is not paid at the Effective Time will begin accruing interest as of the Effective Time at the short-term federal rate. |
Filing footnotes · ownership attribution and instrument terms
F1: Pursuant to the terms of and subject to certain exceptions set forth in the Agreement and Plan of Merger, dated as of September 14, 2016 (the "Merger Agreement"), by and among Bayer Aktiengesellschaft ("Bayer"), KWA Investment Co. ("Merger Sub") and Monsanto Company (the "Company"), each share of common stock of the Company and each time- or performance-vesting restricted stock unit of the Company outstanding immediately prior to the effective time of the merger (the "Effective Time") was automatically converted into the right to receive $128.00 in cash, without interest (the "Merger Consideration").
F2: (Continued from Footnote 1) The Merger Consideration that is payable in respect of restricted stock units of the Company that were granted (a) prior to September 14, 2016 is fully vested as of the Effective Time or (b) after September 14, 2016 will vest based upon the vesting schedule applicable to the corresponding restricted stock units (subject to accelerated vesting in full upon a termination of employment without cause, for good reason or due to death, disability or retirement). Any Merger Consideration that is not paid at the Effective Time will begin accruing interest as of the Effective Time at the short-term federal rate.
F3: Pursuant to the terms of the Merger Agreement, each option to purchase shares of common stock of the Company outstanding immediately prior to the Effective Time, whether vested or unvested, was automatically converted into the right to receive the Merger Consideration less the applicable exercise price of such option, without interest.
F4: Represents restricted stock units.
F5: Represents performance-based restricted stock units.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 07, 2018 Filed Jun 7, 2018 17:09 UTC | MONSANTO CO /NEW/ MON · Entity 165931 | Disposition to issuerStock Option (Right to Buy) · Derivative | 7 | Not disclosed Strike: $58.71 | Not disclosed |
DisclosureSEC source: 0000899243-18-015517 · doc4.xml · derivative · entry 5 MIZELL STEVEN · CIK 0001189403 · EVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7 shares Expires not disclosed F3 · price: Pursuant to the terms of the Merger Agreement, each option to purchase shares of common stock of the Company outstanding immediately prior to the Effective Time, whether vested or unvested, was automatically converted into the right to receive the Merger Consideration less the applicable exercise price of such option, without interest. F3 · derivative.exercise_date: Pursuant to the terms of the Merger Agreement, each option to purchase shares of common stock of the Company outstanding immediately prior to the Effective Time, whether vested or unvested, was automatically converted into the right to receive the Merger Consideration less the applicable exercise price of such option, without interest. F3 · derivative.expiration_date: Pursuant to the terms of the Merger Agreement, each option to purchase shares of common stock of the Company outstanding immediately prior to the Effective Time, whether vested or unvested, was automatically converted into the right to receive the Merger Consideration less the applicable exercise price of such option, without interest. Read SEC document |
| June 07, 2018 Filed Jun 7, 2018 17:09 UTC | MONSANTO CO /NEW/ MON · Entity 165931 | Disposition to issuerCommon Stock | 19,787 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-18-015517 · doc4.xml · nonDerivative · entry 4 MIZELL STEVEN · CIK 0001189403 · EVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F5 · shares: Represents performance-based restricted stock units. F1 · price: Pursuant to the terms of and subject to certain exceptions set forth in the Agreement and Plan of Merger, dated as of September 14, 2016 (the "Merger Agreement"), by and among Bayer Aktiengesellschaft ("Bayer"), KWA Investment Co. ("Merger Sub") and Monsanto Company (the "Company"), each share of common stock of the Company and each time- or performance-vesting restricted stock unit of the Company outstanding immediately prior to the effective time of the merger (the "Effective Time") was automatically converted into the right to receive $128.00 in cash, without interest (the "Merger Consideration"). F2 · price: (Continued from Footnote 1) The Merger Consideration that is payable in respect of restricted stock units of the Company that were granted (a) prior to September 14, 2016 is fully vested as of the Effective Time or (b) after September 14, 2016 will vest based upon the vesting schedule applicable to the corresponding restricted stock units (subject to accelerated vesting in full upon a termination of employment without cause, for good reason or due to death, disability or retirement). Any Merger Consideration that is not paid at the Effective Time will begin accruing interest as of the Effective Time at the short-term federal rate. Read SEC document |
| June 07, 2018 Filed Jun 7, 2018 17:09 UTC | MONSANTO CO /NEW/ MON · Entity 165931 | Disposition to issuerCommon Stock | 48,581 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-18-015517 · doc4.xml · nonDerivative · entry 3 MIZELL STEVEN · CIK 0001189403 · EVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F4 · shares: Represents restricted stock units. F1 · price: Pursuant to the terms of and subject to certain exceptions set forth in the Agreement and Plan of Merger, dated as of September 14, 2016 (the "Merger Agreement"), by and among Bayer Aktiengesellschaft ("Bayer"), KWA Investment Co. ("Merger Sub") and Monsanto Company (the "Company"), each share of common stock of the Company and each time- or performance-vesting restricted stock unit of the Company outstanding immediately prior to the effective time of the merger (the "Effective Time") was automatically converted into the right to receive $128.00 in cash, without interest (the "Merger Consideration"). F2 · price: (Continued from Footnote 1) The Merger Consideration that is payable in respect of restricted stock units of the Company that were granted (a) prior to September 14, 2016 is fully vested as of the Effective Time or (b) after September 14, 2016 will vest based upon the vesting schedule applicable to the corresponding restricted stock units (subject to accelerated vesting in full upon a termination of employment without cause, for good reason or due to death, disability or retirement). Any Merger Consideration that is not paid at the Effective Time will begin accruing interest as of the Effective Time at the short-term federal rate. Read SEC document |
| June 07, 2018 Filed Jun 7, 2018 17:09 UTC | MONSANTO CO /NEW/ MON · Entity 165931 | Disposition to issuerCommon Stock | 1,024 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-18-015517 · doc4.xml · nonDerivative · entry 2 MIZELL STEVEN · CIK 0001189403 · EVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By 401(k) Plan Disclosed balance after: 0 F1 · price: Pursuant to the terms of and subject to certain exceptions set forth in the Agreement and Plan of Merger, dated as of September 14, 2016 (the "Merger Agreement"), by and among Bayer Aktiengesellschaft ("Bayer"), KWA Investment Co. ("Merger Sub") and Monsanto Company (the "Company"), each share of common stock of the Company and each time- or performance-vesting restricted stock unit of the Company outstanding immediately prior to the effective time of the merger (the "Effective Time") was automatically converted into the right to receive $128.00 in cash, without interest (the "Merger Consideration"). F2 · price: (Continued from Footnote 1) The Merger Consideration that is payable in respect of restricted stock units of the Company that were granted (a) prior to September 14, 2016 is fully vested as of the Effective Time or (b) after September 14, 2016 will vest based upon the vesting schedule applicable to the corresponding restricted stock units (subject to accelerated vesting in full upon a termination of employment without cause, for good reason or due to death, disability or retirement). Any Merger Consideration that is not paid at the Effective Time will begin accruing interest as of the Effective Time at the short-term federal rate. Read SEC document |
| June 07, 2018 Filed Jun 7, 2018 17:09 UTC | MONSANTO CO /NEW/ MON · Entity 165931 | Disposition to issuerCommon Stock | 62 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-18-015517 · doc4.xml · nonDerivative · entry 1 MIZELL STEVEN · CIK 0001189403 · EVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · price: Pursuant to the terms of and subject to certain exceptions set forth in the Agreement and Plan of Merger, dated as of September 14, 2016 (the "Merger Agreement"), by and among Bayer Aktiengesellschaft ("Bayer"), KWA Investment Co. ("Merger Sub") and Monsanto Company (the "Company"), each share of common stock of the Company and each time- or performance-vesting restricted stock unit of the Company outstanding immediately prior to the effective time of the merger (the "Effective Time") was automatically converted into the right to receive $128.00 in cash, without interest (the "Merger Consideration"). F2 · price: (Continued from Footnote 1) The Merger Consideration that is payable in respect of restricted stock units of the Company that were granted (a) prior to September 14, 2016 is fully vested as of the Effective Time or (b) after September 14, 2016 will vest based upon the vesting schedule applicable to the corresponding restricted stock units (subject to accelerated vesting in full upon a termination of employment without cause, for good reason or due to death, disability or retirement). Any Merger Consideration that is not paid at the Effective Time will begin accruing interest as of the Effective Time at the short-term federal rate. Read SEC document |
| May 15, 2018 Filed May 17, 2018 18:47 UTC | OSHKOSH CORP OSK · Entity 3573 | GrantCommon Stock | 254.24 | $74.96 | $19,057.83 |
DisclosureSEC source: 0000775158-18-000066 · edgar.xml · nonDerivative · entry 1 MIZELL STEVEN · CIK 0001189403 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,010.44 F1 · shares: Represents stock units payable in Oshkosh Corporation common stock acquired in accordance with the automatic purchase feature of the Oshkosh Corporation Deferred Compensation Plan for Directors and Executive Officers. Read SEC document |
| May 14, 2018 Filed May 15, 2018 18:18 UTC | OSHKOSH CORP OSK · Entity 3573 | GrantCommon Stock | 34.34 | $74.77 | $2,567.60 |
DisclosureSEC source: 0000775158-18-000062 · edgar.xml · nonDerivative · entry 1 MIZELL STEVEN · CIK 0001189403 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,756.2 F1 · shares: Represents stock units payable in Oshkosh Corporation common stock acquired in accordance with the dividend reinvestment feature of the Oshkosh Corporation Deferred Compensation Plan for Directors and Executive Officers. Read SEC document |
| February 15, 2018 Filed Feb 20, 2018 18:43 UTC | OSHKOSH CORP OSK · Entity 3573 | GrantCommonStock | 218.95 | $87.04 | $19,057.41 |
DisclosureSEC source: 0000775158-18-000030 · edgar.xml · nonDerivative · entry 1 MIZELL STEVEN · CIK 0001189403 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,721.86 F1 · shares: Represents stock units payable in Oshkosh Corporation common stock acquired in accordance with the automatic purchase feature of the Oshkosh Corporation Deferred Compensation Plan for Directors and Executive Officers. Read SEC document |
| February 12, 2018 Filed Feb 13, 2018 20:20 UTC | OSHKOSH CORP OSK · Entity 3573 | GrantCommon Stock | 29.11 | $86.15 | $2,507.83 |
DisclosureSEC source: 0000775158-18-000022 · edgar.xml · nonDerivative · entry 1 MIZELL STEVEN · CIK 0001189403 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,502.91 F1 · shares: Represents stock units payable in Oshkosh Corporation common stock acquired in accordance with the dividend reinvestment feature of the Oshkosh Corporation Deferred Compensation Plan for Directors and Executive Officers. Read SEC document |
| February 06, 2018 Filed Feb 8, 2018 16:23 UTC | OSHKOSH CORP OSK · Entity 3573 | GrantCommon Stock | 1,625 | $0.00 | $0.00 |
DisclosureSEC source: 0000775158-18-000012 · edgar.xml · nonDerivative · entry 1 MIZELL STEVEN · CIK 0001189403 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,473.8 F1 · shares: Common Stock granted to Reporting Person pursuant to the Company's 2017 Incentive Stock and Awards Plan and deferred by Reporting Person pursuant to the Company's Deferred Compensation Plan for Directors and Executive Officers. Read SEC document |
| January 09, 2018 Filed Jan 11, 2018 16:17 UTC | MONSANTO CO /NEW/ MON · Entity 165931 | Exercise / conversionOption (Right to Buy) · Derivative | 7,000 | $0.00 Strike: $91.34 | $0.00 |
DisclosureSEC source: 0001110783-18-000011 · edgar.xml · derivative · entry 4 MIZELL STEVEN · CIK 0001189403 · EVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,234 Underlying: Common Stock · 7,000 shares Expires 2025-10-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: One-third of the options became exercisable on November 15, 2016, one-third of the options became exercisable on November 15, 2017 and the remainder of the options become exercisable on November 15, 2018, subject to the terms and conditions of the Monsanto Company 2005 Long Term Incentive Plan. Read SEC document |
| January 09, 2018 Filed Jan 11, 2018 16:17 UTC | MONSANTO CO /NEW/ MON · Entity 165931 | SaleCommon Stock | 8,100 | $119.35 | $966,719.61 |
DisclosureSEC source: 0001110783-18-000011 · edgar.xml · nonDerivative · entry 2 MIZELL STEVEN · CIK 0001189403 · EVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,643 F1 · price: This price represents the weighted average sale price for multiple transactions reported on this line. The prices of the transactions reported on this line ranged from $119.34 to $119.35. Upon request by the Commission staff, the issuer or a security holder of the issuer, the reporting person will undertake to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| January 09, 2018 Filed Jan 11, 2018 16:17 UTC | MONSANTO CO /NEW/ MON · Entity 165931 | Exercise / conversionCommon Stock | 7,000 | $91.34 | $639,380.00 |
DisclosureSEC source: 0001110783-18-000011 · edgar.xml · nonDerivative · entry 1 MIZELL STEVEN · CIK 0001189403 · EVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,743 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 16, 2017 Filed Nov 17, 2017 19:11 UTC | OSHKOSH CORP OSK · Entity 3573 | GrantCommon Stock | 24.48 | $84.60 | $2,071.01 |
DisclosureSEC source: 0000775158-17-000167 · edgar.xml · nonDerivative · entry 2 MIZELL STEVEN · CIK 0001189403 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,848.8 F2 · shares: Represents stock units payable in Oshkosh Corporation common stock acquired in accordance with the dividend reinvestment feature of the Oshkosh Corporation Deferred Compensation Plan for Directors and Executive Officers. Read SEC document |
| November 15, 2017 Filed Nov 16, 2017 16:37 UTC | MONSANTO CO /NEW/ MON · Entity 165931 | Tax withholdingCommon Stock | 967 | $117.26 | $113,390.42 |
DisclosureSEC source: 0001110783-17-000271 · edgar.xml · nonDerivative · entry 1 MIZELL STEVEN · CIK 0001189403 · EVP/Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,743 F1 · shares: On November 15, 2017, 2,120 time-based restricted stock units became fully vested for which taxes became due and payable. 967 restricted stock units were used for the payment of these taxes. Read SEC document |
| November 15, 2017 Filed Nov 17, 2017 19:11 UTC | OSHKOSH CORP OSK · Entity 3573 | GrantCommon Stock | 172.69 | $84.06 | $14,516.32 |
DisclosureSEC source: 0000775158-17-000167 · edgar.xml · nonDerivative · entry 1 MIZELL STEVEN · CIK 0001189403 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,824.32 F1 · shares: Represents stock units payable in Oshkosh Corporation common stock acquired in accordance with the automatic purchase feature of the Oshkosh Corporation Deferred Compensation Plan for Directors and Executive Officers. Read SEC document |
| October 26, 2017 Filed Oct 30, 2017 16:18 UTC | MONSANTO CO /NEW/ MON · Entity 165931 | GrantCommon Stock | 6,999 | $0.00 | $0.00 |
DisclosureSEC source: 0001110783-17-000215 · edgar.xml · nonDerivative · entry 2 MIZELL STEVEN · CIK 0001189403 · EVP/Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,709 F2 · shares: Restricted stock unit grant pursuant to the Monsanto Company 2005 Long-Term Incentive Plan, vesting one-third on November 15, 2018, one-third on November 15, 2019 and the remaining one-third on November 15, 2020. Read SEC document |
| October 26, 2017 Filed Oct 30, 2017 16:18 UTC | MONSANTO CO /NEW/ MON · Entity 165931 | GrantCommon Stock | 6,999 | $0.00 | $0.00 |
DisclosureSEC source: 0001110783-17-000215 · edgar.xml · nonDerivative · entry 1 MIZELL STEVEN · CIK 0001189403 · EVP/Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,710 F1 · shares: Restricted stock unit grant pursuant to the Monsanto Company 2005 Long-Term Incentive Plan, vesting on November 15, 2017. Read SEC document |
| October 26, 2017 Filed Nov 16, 2017 16:35 UTC Amendment | MONSANTO CO /NEW/ MON · Entity 165931 | OtherCommon Stock | 0 | $0.00 | $0.00 |
DisclosureSEC source: 0001110783-17-000270 · edgar.xml · nonDerivative · entry 1 MIZELL STEVEN · CIK 0001189403 · EVP/Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,710 F1 · balance_after: On October 30, 2017, the Company mistakenly filed a Form 4 on the reporting person's behalf reporting the grant of 6,999 restricted stock units vesting on November 15, 2017 as an acquisition of common stock that did not occur. This amended Form 4 is being filed to reflect the deletion of such transaction. The remaining transaction(s) contained in such Form 4 are not amended hereby. Read SEC document |
| October 09, 2017 Filed Oct 11, 2017 16:11 UTC | MONSANTO CO /NEW/ MON · Entity 165931 | Exercise / conversionOption (Right to Buy) · Derivative | 11,526 | $0.00 Strike: $112.82 | $0.00 |
DisclosureSEC source: 0001110783-17-000176 · edgar.xml · derivative · entry 4 MIZELL STEVEN · CIK 0001189403 · EVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,764 Underlying: Common Stock · 11,526 shares Expires 2024-10-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: One-third of the options became exercisable on November 15, 2015, one-third of the options became exercisable on November 15, 2016 and the remainder of the options become exercisable on November 15, 2017, subject to the terms and conditions of the Monsanto Company 2005 Long Term Incentive Plan. Read SEC document |
| October 09, 2017 Filed Oct 11, 2017 16:11 UTC | MONSANTO CO /NEW/ MON · Entity 165931 | SaleCommon Stock | 11,526 | $119.70 | $1,379,716.37 |
DisclosureSEC source: 0001110783-17-000176 · edgar.xml · nonDerivative · entry 2 MIZELL STEVEN · CIK 0001189403 · EVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,711 F1 · price: This price represents the weighted average sale price for multiple transactions reported on this line. The prices of the transactions reported on this line ranged from $119.70 to $119.7250. Upon request by the Commission staff, the issuer or a security holder of the issuer, the reporting person will undertake to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| October 09, 2017 Filed Oct 11, 2017 16:11 UTC | MONSANTO CO /NEW/ MON · Entity 165931 | Exercise / conversionCommon Stock | 11,526 | $112.82 | $1,300,363.32 |
DisclosureSEC source: 0001110783-17-000176 · edgar.xml · nonDerivative · entry 1 MIZELL STEVEN · CIK 0001189403 · EVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,237 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 18, 2017 Filed Aug 22, 2017 19:34 UTC | OSHKOSH CORP OSK · Entity 3573 | GrantCommon Stock | 24.62 | $73.38 | $1,806.62 |
DisclosureSEC source: 0000775158-17-000090 · edgar.xml · nonDerivative · entry 1 MIZELL STEVEN · CIK 0001189403 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,651.63 F1 · shares: Represents stock units payable in Oshkosh Corporation common stock acquired in accordance with the dividend reinvestment feature of the Oshkosh Corporation Deferred Compensation Plan for Directors and Executive Officers. Read SEC document |
| August 15, 2017 Filed Aug 16, 2017 14:57 UTC | OSHKOSH CORP OSK · Entity 3573 | GrantCommon Stock | 192.45 | $75.43 | $14,516.50 |
DisclosureSEC source: 0000775158-17-000089 · edgar.xml · nonDerivative · entry 1 MIZELL STEVEN · CIK 0001189403 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,627.01 F1 · shares: Represents stock units payable in Oshkosh Corporation common stock acquired in accordance with the automatic purchase feature of the Oshkosh Corporation Deferred Compensation Plan for Directors and Executive Officers. Read SEC document |
| July 03, 2017 Filed Jul 6, 2017 16:18 UTC | MONSANTO CO /NEW/ MON · Entity 165931 | Exercise / conversionOption (Right to Buy) · Derivative | 11,300 | $0.00 Strike: $106.05 | $0.00 |
DisclosureSEC source: 0001110783-17-000104 · edgar.xml · derivative · entry 4 MIZELL STEVEN · CIK 0001189403 · EVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80 Underlying: Common Stock · 11,300 shares Expires 2023-10-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: One-third of the options became exercisable on November 15, 2014, one-third of the options became exercisable on November 15, 2015 and the remainder of the options became exercisable on November 15, 2016, subject to the terms and conditions of the Monsanto Company 2005 Long Term Incentive Plan. Read SEC document |
| July 03, 2017 Filed Jul 6, 2017 16:18 UTC | MONSANTO CO /NEW/ MON · Entity 165931 | SaleCommon Stock | 11,300 | $118.57 | $1,339,869.25 |
DisclosureSEC source: 0001110783-17-000104 · edgar.xml · nonDerivative · entry 2 MIZELL STEVEN · CIK 0001189403 · EVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,711 F1 · price: This price represents the weighted average sale price for multiple transactions reported on this line. The prices of the transactions reported on this line ranged from $118.53 to $118.615. Upon request by the Commission staff, the issuer or a security holder of the issuer, the reporting person will undertake to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| July 03, 2017 Filed Jul 6, 2017 16:18 UTC | MONSANTO CO /NEW/ MON · Entity 165931 | Exercise / conversionCommon Stock | 11,300 | $106.05 | $1,198,365.00 |
DisclosureSEC source: 0001110783-17-000104 · edgar.xml · nonDerivative · entry 1 MIZELL STEVEN · CIK 0001189403 · EVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,011 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 15, 2017 Filed May 16, 2017 19:30 UTC | OSHKOSH CORP OSK · Entity 3573 | GrantCommon Stock | 220.81 | $65.74 | $14,516.05 |
DisclosureSEC source: 0000775158-17-000062 · edgar.xml · nonDerivative · entry 2 MIZELL STEVEN · CIK 0001189403 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,434.56 F2 · shares: Represents stock units payable in Oshkosh Corporation common stock acquired in accordance with the automatic purchase feature of the Oshkosh Corporation Deferred Compensation Plan for Directors and Executive Officers. Read SEC document |
| May 12, 2017 Filed May 16, 2017 19:30 UTC | OSHKOSH CORP OSK · Entity 3573 | GrantCommon Stock | 26.2 | $65.41 | $1,713.74 |
DisclosureSEC source: 0000775158-17-000062 · edgar.xml · nonDerivative · entry 1 MIZELL STEVEN · CIK 0001189403 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,213.75 F1 · shares: Represents stock units payable in Oshkosh Corporation common stock acquired in accordance with the dividend reinvestment feature of the Oshkosh Corporation Deferred Compensation Plan for Directors and Executive Officers. Read SEC document |
| April 28, 2017 Filed May 2, 2017 19:01 UTC | OSHKOSH CORP OSK · Entity 3573 | SaleCommon Stock | 1,800 | $69.80 | $125,640.00 |
DisclosureSEC source: 0000775158-17-000053 · edgar.xml · nonDerivative · entry 1 MIZELL STEVEN · CIK 0001189403 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,187.55 Read SEC document |
| April 10, 2017 Filed Apr 12, 2017 16:05 UTC | MONSANTO CO /NEW/ MON · Entity 165931 | Exercise / conversionOption (Right to Buy) · Derivative | 7,116 | $0.00 Strike: $91.34 | $0.00 |
DisclosureSEC source: 0001110783-17-000050 · edgar.xml · derivative · entry 6 MIZELL STEVEN · CIK 0001189403 · EVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,234 Underlying: Common Stock · 7,116 shares Expires 2025-10-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: One-third of the options became exercisable on November 15, 2016, one-third of the options become exercisable on November 15, 2017 and the remainder of the options become exercisable on November 15, 2018, subject to the terms and conditions of the Monsanto Company 2005 Long-Term Incentive Plan. Read SEC document |
| April 10, 2017 Filed Apr 12, 2017 16:05 UTC | MONSANTO CO /NEW/ MON · Entity 165931 | Exercise / conversionOption (Right to Buy) · Derivative | 6,584 | $0.00 Strike: $90.48 | $0.00 |
DisclosureSEC source: 0001110783-17-000050 · edgar.xml · derivative · entry 5 MIZELL STEVEN · CIK 0001189403 · EVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91 Underlying: Common Stock · 6,584 shares Expires 2022-10-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: One-third of the options became exercisable on November 15, 2013, one-third of the options became exercisable on November 15, 2014 and the remainder of the options became exercisable on November 15, 2015, subject to the terms and conditions of the Monsanto Company 2005 Long Term Incentive Plan. Read SEC document |
| April 10, 2017 Filed Apr 12, 2017 16:05 UTC | MONSANTO CO /NEW/ MON · Entity 165931 | SaleCommon Stock | 13,700 | $116.11 | $1,590,748.10 |
DisclosureSEC source: 0001110783-17-000050 · edgar.xml · nonDerivative · entry 3 MIZELL STEVEN · CIK 0001189403 · EVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,711 F1 · price: This price represents the weighted average sale price for multiple transactions reported on this line. The prices of the transactions reported on this line ranged from $116.10 to $116.20. Upon request by the Commission staff, the issuer or a security holder of the issuer, the reporting person will undertake to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| April 10, 2017 Filed Apr 12, 2017 16:05 UTC | MONSANTO CO /NEW/ MON · Entity 165931 | Exercise / conversionCommon Stock | 7,116 | $91.34 | $649,975.44 |
DisclosureSEC source: 0001110783-17-000050 · edgar.xml · nonDerivative · entry 2 MIZELL STEVEN · CIK 0001189403 · EVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,411 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 10, 2017 Filed Apr 12, 2017 16:05 UTC | MONSANTO CO /NEW/ MON · Entity 165931 | Exercise / conversionCommon Stock | 6,584 | $90.48 | $595,720.32 |
DisclosureSEC source: 0001110783-17-000050 · edgar.xml · nonDerivative · entry 1 MIZELL STEVEN · CIK 0001189403 · EVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,295 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 15, 2017 Filed Feb 16, 2017 15:14 UTC | OSHKOSH CORP OSK · Entity 3573 | GrantCommon Stock | 209.11 | $69.42 | $14,516.42 |
DisclosureSEC source: 0000775158-17-000029 · edgar.xml · nonDerivative · entry 1 MIZELL STEVEN · CIK 0001189403 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,987.55 F1 · shares: Represents stock units payable in Oshkosh Corporation common stock acquired in accordance with the automatic purchase feature of the Oshkosh Corporation Deferred Compensation Plan for Directors and Executive Officers. Read SEC document |
| February 13, 2017 Filed Feb 15, 2017 16:54 UTC | OSHKOSH CORP OSK · Entity 3573 | GrantCommon Stock | 24.36 | $68.33 | $1,664.52 |
DisclosureSEC source: 0000775158-17-000017 · edgar.xml · nonDerivative · entry 1 MIZELL STEVEN · CIK 0001189403 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,778.44 F1 · shares: Represents stock units payable in Oshkosh Corporation common stock acquired in accordance with the dividend reinvestment feature of the Oshkosh Corporation Deferred Compensation Plan for Directors and Executive Officers. Read SEC document |
| February 07, 2017 Filed Feb 9, 2017 21:26 UTC | OSHKOSH CORP OSK · Entity 3573 | GrantCommon Stock | 2,025 | $0.00 | $0.00 |
DisclosureSEC source: 0000775158-17-000009 · edgar.xml · nonDerivative · entry 1 MIZELL STEVEN · CIK 0001189403 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,754.08 F1 · shares: Common Stock granted to Reporting Person pursuant to the Company's 2017 Incentive Stock and Awards Plan and deferred by Reporting Person pursuant to the Company's Deferred Compensation Plan for Directors and Executive Officers. Read SEC document |
| January 10, 2017 Filed Jan 12, 2017 16:27 UTC | MONSANTO CO /NEW/ MON · Entity 165931 | SaleCommon Stock | 2,525 | $108.56 | $274,114.00 |
DisclosureSEC source: 0001110783-17-000010 · edgar.xml · nonDerivative · entry 1 MIZELL STEVEN · CIK 0001189403 · EVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,711 F1 · price: This price represents the weighted average sale price for multiple transactions reported on this line. The prices of the transactions reported on this line ranged from $108.54 to $108.57. Upon request by the Commission staff, the issuer or a security holder of the issuer, the reporting person will undertake to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| November 17, 2016 Filed Nov 18, 2016 20:04 UTC | OSHKOSH CORP OSK · Entity 3573 | GrantCommon Stock | 18.52 | $66.74 | $1,236.02 |
DisclosureSEC source: 0000775158-16-000390 · edgar.xml · nonDerivative · entry 1 MIZELL STEVEN · CIK 0001189403 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,729.08 F1 · shares: Represents stock units payable in Oshkosh Corporation common stock acquired in accordance with the dividend reinvestment feature of the Oshkosh Corporation Deferred Compensation Plan for Directors and Executive Officers. Read SEC document |
| November 15, 2016 Filed Nov 17, 2016 16:21 UTC | OSHKOSH CORP OSK · Entity 3573 | GrantCommon Stock | 179.74 | $67.13 | $12,065.95 |
DisclosureSEC source: 0000775158-16-000388 · edgar.xml · nonDerivative · entry 1 MIZELL STEVEN · CIK 0001189403 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,710.56 F1 · shares: Represents stock units payable in Oshkosh Corporation common stock acquired in accordance with the automatic purchase feature of the Oshkosh Corporation Deferred Compensation Plan for Directors and Executive Officers. Read SEC document |
| November 15, 2016 Filed Nov 17, 2016 16:23 UTC | MONSANTO CO /NEW/ MON · Entity 165931 | Tax withholdingCommon Stock | 1,269 | $99.09 | $125,745.21 |
DisclosureSEC source: 0001110783-16-000599 · edgar.xml · nonDerivative · entry 1 MIZELL STEVEN · CIK 0001189403 · EVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,236 F1 · shares: On November 15, 2016, 3,803 performance-based restricted stock units became fully vested for which taxes became due and payable. 1,269 restricted stock units were used for the payment of these taxes. Read SEC document |
| October 17, 2016 Filed Oct 19, 2016 17:26 UTC | MONSANTO CO /NEW/ MON · Entity 165931 | GrantCommon Stock | 6,362 | $0.00 | $0.00 |
DisclosureSEC source: 0001110783-16-000543 · edgar.xml · nonDerivative · entry 2 MIZELL STEVEN · CIK 0001189403 · EVP/Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,505 F2 · shares: Restricted stock unit grant pursuant to the Monsanto Company 2005 Long-Term Incentive Plan, vesting one-third on November 15, 2017, one-third on November 15, 2018 and the remaining one-third on November 15, 2019. Read SEC document |
| October 17, 2016 Filed Oct 19, 2016 17:26 UTC | MONSANTO CO /NEW/ MON · Entity 165931 | GrantCommon Stock | 3,803 | $0.00 | $0.00 |
DisclosureSEC source: 0001110783-16-000543 · edgar.xml · nonDerivative · entry 1 MIZELL STEVEN · CIK 0001189403 · EVP/Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,143 F1 · shares: Restricted stock unit grant pursuant to the Monsanto Company 2005 Long-Term Incentive Plan, vesting on November 15, 2016. Read SEC document |
| October 10, 2016 Filed Oct 12, 2016 16:53 UTC | MONSANTO CO /NEW/ MON · Entity 165931 | SaleCommon Stock | 310 | $103.09 | $31,957.90 |
DisclosureSEC source: 0001110783-16-000518 · edgar.xml · nonDerivative · entry 1 MIZELL STEVEN · CIK 0001189403 · EVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,340 F1 · balance_after: Reflects corrected amount of securities beneficially owned, which was mistakenly reported on Form 4 filed April 18, 2016 as 310. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.